We recently published a list of Was Jim Cramer Right About These 11 Stocks? In this article, we are going to take a look at ...

Gilgamesh Pharmaceuticals, a clinical-stage neuroscience company developing innovative, best-in-class new chemical entities (NCEs) that transform the treatment paradigm for psychiatric diseases, today ...

BYD Co. shares extended losses in Hong Kong trading Tuesday — taking their two-day slide to more than 10% — as last week’s ...

How will we live, work, spend and play in an AI-enabled future? As an editor overseeing the news agenda for WSJ’s annual ...

With Goodyear's entry, SDVerse continues its mission to transform automotive software sourcing - connecting buyers and sellers, accelerating innovation, and enabling software-defined mobility at scale ...

Brazilian firm WEG has created $21.1 billion in wealth for the descendants of its founders. Now it’s facing what may be its ...